Previous 10 | Next 10 |
2024-05-01 13:15:11 ET Image source: The Motley Fool. CVS Health (NYSE: CVS) Q1 2024 Earnings Call May 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: CVS Health (CVS) Q1 2024 Earnings Call Transcript
2024-05-01 13:03:51 ET More on CVS Health CVS Health Corporation (CVS) Q1 2024 Earnings Call Transcript CVS Health Corporation 2024 Q1 - Results - Earnings Call Presentation CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot Biggest stock mov...
2024-05-01 12:27:29 ET Shares of CVS Health (NYSE: CVS) dove Wednesday morning after the diversified pharmacy and health insurance company posted disappointing results in its first-quarter earnings report and cut its guidance for the year. As of 12:01 p.m. ET, the stock was down...
2024-05-01 12:12:07 ET CVS Health Corporation (CVS) Q1 2024 Earnings Conference Call May 1, 2024 08:00 a.m. ET Company Participants Karen Lynch - President, Chief Executive Officer Tom Cowhey - Chief Financial Officer David Falkowski - Executive Vice President, C...
A look at the top 10 most actives in Canada Lifeist Wellness Inc. (LFST) fell 33.3% to $0.005 on volume of 6,512,534 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 4.7% to $3.26 on volume of 2,735,943 shares Anfield Energy Inc. (AEC) rose 13.3% to $0.085 on volume of 2,467...
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...
2024-05-01 08:34:29 ET More on pre-market losers & stocks. NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript NRx P...
2024-05-01 07:17:39 ET More on CVS Health CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot CVS Health: Seizing Opportunity Amid Recent Declines CVS Health: Good Management Is Keeping Their Promises CVS Health Non-GAAP EPS of $1.31 misses by...
2024-05-01 07:06:29 ET More on CVS Health CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot CVS Health: Seizing Opportunity Amid Recent Declines CVS Health: Good Management Is Keeping Their Promises CVS Health Non-GAAP EPS of $1.31 misses by...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...